ArticleFrontiers in psychiatry2020
The Predictive Validity of Machine Learning Models in the Classification and Treatment of Major Depressive Disorder: State of the Art and Future Directions.
Article in Frontiers in psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Machine learning approaches in the therapeutic outcome prediction in major depressive disorder: a systematic review.Frontiers in psychiatry · 2025Pooled it
- Development of a baseline battery to optimize depression treatment assignment in primary care: Balancing breadth and brevity.Journal of affective disorders · 2026Article
- A Random Forest-Based Risk Prediction Model for Non-Response to Methylphenidate in Children with Attention Deficit Hyperactivity Disorder.Neuropsychiatric disease and treatment · 2026Article
- Machine Learning Model for Response to Internet-Delivered CBT vs Antidepressant Medication.JAMA network open · 2025Article
- Prediction of treatment-resistant depression using the 23andMe survey data.Scientific reports · 2025Article
- Optimizing treatment for depression in primary care using psychotherapy versus antidepressant medication in a low-resource setting: protocol for the OptimizeD randomized controlled trial.BMC psychiatry · 2025Article
- Development of the treatment prediction model in the artificial intelligence in depression - medication enhancement study.Npj mental health research · 2025Article
- Development of a model to predict antidepressant treatment response for depression among Veterans.Psychological medicine · 2023Article
- Bayesian network analysis of antidepressant treatment trajectories.Scientific reports · 2023Article
- Temporal multi-step predictive modeling of remission in major depressive disorder using early stage treatment data; STAR*D based machine learning approach.Journal of affective disorders · 2023Article
- The Precision in Psychiatry (PIP) study: Testing an internet-based methodology for accelerating research in treatment prediction and personalisation.BMC psychiatry · 2023Article
- Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies.Molecular psychiatry · 2023Review
- Information extraction from free text for aiding transdiagnostic psychiatry: constructing NLP pipelines tailored to clinicians' needs.BMC psychiatry · 2022Article
- Feasibility of Repeated Assessment of Cognitive Function in Older Adults Using a Wireless, Mobile, Dry-EEG Headset and Tablet-Based Games.Frontiers in psychiatry · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder imposes a substantial disease burden worldwide, ranking as the third leading contributor to global disability. In spite of its ubiquity, classifying and treating depression has proven troublesome. One argument put forward to explain this predicament is the heterogeneity of patients diagnosed with the disorder. Recently, many areas of daily life have witnessed the surge of machine learning techniques, computational approaches to elucidate complex patterns in large datasets, which can be employed to make predictions and detect relevant clusters. Due to the multidimensionality at play in the pathogenesis of depression, it is suggested that machine learning could contribute to improving classification and treatment. In this paper, we investigated literature focusing on the use of machine learning models on datasets with clinical variables of patients diagnosed with depression to predict treatment outcomes or find more homogeneous subgroups. Identified studies based on best practices in the field are evaluated. We found 16 studies predicting outcomes (such as remission) and identifying clusters in patients with depression. The identified studies are mostly still in proof-of-concept phase, with small datasets, lack of external validation, and providing single performance metrics. Larger datasets, and models with similar variables present across these datasets, are needed to develop accurate and generalizable models. We hypothesize that harnessing natural language processing to obtain data 'hidden' in clinical texts might prove useful in improving prediction models. Besides, researchers will need to focus on the conditions to feasibly implement these models to support psychiatrists and patients in their decision-making in practice. Only then we can enter the realm of precision psychiatry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.